Distribution of capsular types and antimicrobial susceptibility of Streptococcus agalactiae causing infections in Argentina;Distribución de tipo capsular y sensibilidad antimicrobiana de Streptococcus agalactiae productores de infecciones en Argentina

Revista Argentina de Microbiologia

Volumn 36, Issue 2, 2004, Pages 63-67

  Perez, J ^a   Limansky, A ^a   Toresani, I ^a   Ebner, G ^a   Di Bartolomeo, S ^b   De Inocenti, I ^c   Pretto, G ^c   Salazar, N ^d   Laferrara, M ^d   Bottiglieri, M ^e   Ballester, D ^f   Morales, M ^f   Rivera, L ^f   Cacace, M L ^g   Castro, H ^h   Roldan L ⁱ   Notario, R ^j   Borda, N ^j   Cera, G ^k   Spoletti, M J ^k   Gregorini, E ^k   Sutich, E G ^{a,b,c,d,e,f,g,h,i,j,k,l}   more..

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^b Hosp Posadas Palomar   (Argentina)

^c Hosp R Saenz Peña   (Argentina)

^d Hospital Regional Rio Grande   (Argentina)

^e UNIVERSIDAD CATÓLICA DE CÓRDOBA   (Argentina)

^f Hosp Gen Agudos Parmenio T Pinero   (Argentina)

^g Hosp San V de Paul   (Argentina)

^h Hosp Dr M Quiroga San Juan   (Argentina)

ⁱ Hosp Español ^*  (Argentina)

^j HOSPITAL ESPAÑOL   (Argentina)

^k Hosp Pcial Centenario   (Argentina)

^l Centro Médico IPAM   (Argentina)

more..

Author keywords

Antimicrobial susceptibility; Serotypes; Streptococcus agalactiae

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BACTERIAL POLYSACCHARIDE; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CLINDAMYCIN; ERYTHROMYCIN; LINCOSAMINE DERIVATIVE; MACROLIDE; MEMBRANE PROTEIN; OFLOXACIN; PENICILLIN G; STREPTOGRAMIN; SURFACE PROTEIN C; SURFACE PROTEIN R; SURFACE PROTEIN X; TETRACYCLINE; UNCLASSIFIED DRUG; VACCINE; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARGENTINA; ARTICLE; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CLINICAL TRIAL; GENOTYPE; HEALTH SURVEY; HUMAN; IMMUNE DEFICIENCY; IMMUNIZATION; INFECTION CONTROL; NEWBORN; NEWBORN INFECTION; PERINATAL INFECTION; PHENOTYPE; SEROTYPE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

ARGENTINA; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; VIRULENCE;

EID: 4444281419     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Andrews JI, Diekema DJ, Hunter SK, Rhomberg PR, Pfaller MA, Jones RN, et al (2000) Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibitity and serotyping results from SENTRY centers in the Western Hemisphere. Am.J. Obstet. Gynecol. 183: 859-862.
2. Aracil B, Miñambres M, Oteo J, de la Rosa M, Gomez-Garces, JL, Alós JI (2002). Susceptibility of strains of Streptococcus agalactiae to macrolides and lincosamides, phenotype patterns and resistance genes. Clin. Microbiol. Infect. 8: 745-748.
3. Azavedo J CS de, Mcgavin M, Duncan C, Low DE, Mcgeer A (2001) Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B Streptococcus isolates from Ontario, Canadá. Antimicrob. Agents Chemother. 45: 3504-3508.
4. Bland ML, Vermillion ST, Soper DE, Austin M (2001) Antibiotic resistance patterns of group B streptococci in late third-trimester rectovaginal cultures. Am. J. Obstet. Gynecol. 184: 1125-1126.
5. Blumberg HM, Stephens DS, Modansky M, Erwin M, Elliot J, Fackland RR et al (1996) Invasive group B streptococcal disease: the emergence of serotype V. J. Infect. Dis. 173: 365-373.
6. Edwards M S, Baker C J (2000). Streptococcus agalactiae (group B Streptococcus. En Mandell, GI, Bennett, JE, Dolin, R. (ed), Mandell, Douglas and Bennett's principles and practice of infectious diseases, Churchill Livingstone, Philadelphia, p. 2156-2167.
7. Farley MM (2001) Group B streptococcal disease in nonpregnant adults. Clin. Infect. Dis 33: 556-561.
8. Fernández M, Hickman ME, Baker CJ (1998) Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob. Agents Chemother. 42: 1517-1519.
9. Fitoussi F, Loukil C, Gros I, Clermont O, Mariani P, Bonacorsi S et al (2001) Mechanisms of macrolide resistance in clinical group B streptococci isolated in France. Antimicrob. Agents Chemother 45: 1889-1891.
10. Hsueh PR, Teng LJ, Lee LN, Ho SW, Yang PC, Luh KT (2001) High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan Antimicrob. Agents Chemother 45: 3205-3208.
11. Ko WC, Lee HC, Wang LR, Lee CT, Liu AJ, Wu JJ (2001) Serotyping and antimicrobial susceptibiliy of group B Streptococcus over an eight-year in Southern Taiwan. Eur. J. Clin. Microbiol. Infect. Dis. 20: 334-339.
12. Lancefield RC, Mc Carty M, Everly WN (1975) Múltiple mouse-protective antibodies directed aginst group B streptococci. Special reference to antibodies effective against protein antigens. J. Exp. Med 142: 165-179.
13. Limansky A, Sutich E, Guardati MC, Toresani I, Viale A. (1998) Genomic diversity among Streptococcus agalactiae isolated by a degenerate oligonucleotide-primed amplification assay. J. Infect. Dis. 177: 1308-1313.
14. Luna VA, Coates P, Eady EA, Cove JH, Nguyen TT, Roberts MC (1999) A variety of gram-positive bacteria carry mobile mef genes. J. Antimicrob. Chemother. 44: 19-25.
15. Manning SD, Foxman B, Pierson CL, Tallman P, Baker CJ, Pearlman MD (2003) Correlates of antibiotic-resistant group B Streptococcus isolated from pregnant women. Obstet. Gynecol. 101: 74-79.
16. Morales WJ, Dickey SS, Bornick P, Lim DV (1999) Change in antibiotic resistance of group B Streptococcus: impact on intrapartum manegement. Am. J. Obstet. Gynecol. 181: 310-314.
17. Moyo SR, Mudzori J, Tswana SA, Maeland JA (2000) Prevalence, capsular type distribution, anthropometric and obstetric factors of group B Streptococcus (Streptococcus agalactiae) colonization in pregnancy. Cent. Afr. J. Med. 46: 115-120.
18. Muñoz P, Llancaqueo A, Rodríguez-Creixems M, Pelaez T, Martín L, Bouza E (1997) Group B Streptococcus bacteremia in nonpregnant adults. Arch. Intern. Med. 157, 213-216.
19. Murdoch DR, Barth Reller L (2001) Antimicrobial susceptibilities of Group B isolated from patients with invasive disease: 10-year perspective. Antimicrob. Agents Chemother. 45: 3623-3624.
20. National Committee for Clinical Laboratory Standars (2002) Tabla 2H del M2-A7 Vol. 22 N° 1, Villanova, Estados Unidos de América.
21. Ruess M, Muller U, Sander A, Berner R (2000) Antimicrobial susceptibility patterns of Streptococcus agalactiae in a German university hospital. Scand. J. Infect. Dis. 32: 623-626.
22. Schuchat A, (1998) Epidemiology of group B streptococcal disease in the Uniteds states:shifting paradigms. Clin. Microbiol. Rev. 11: 497-513.
23. Sutich E, Limansky A, Toresani I, Bogado I, Guardati M, Notario R et al. (1996) Estudio de la transmisión materno-neonatal de Streptococcus agalactiae mediante serotipificación y análisis del polimorfismo del ADN Infect. Microbiol. Clin. 8: 14-20.
24. Toresani I, Limansky A, Bogado I, Guardati MC, Viale A, Sutich E (2001) Phenotypic and genotypic study of Streptococcus agalactiae in vagina of pregnant women in Argentina. Medicina (Bs As) 61: 295-300.
25. Toresani I, Limansky A, Francois S, Ebner G, Viale A, Sutich E (2000). Análisis de determinantes de virulencia de una población de Streptococcus agalactiae. XLV Reunión Científica de la Sociedad Argentina de Investigación Clínica y XLVIII Reunión Científica de la Sociedad Argentina de Inmunología- Medicina (BsAs) 60: 839-840.
26. Truppia L, Mollerach A, Perisutti R, Mendosa A, Méndez E (2001) Estudio de sensibilidad de 115 cepas de Streptococcus agalactiae a distintos antimicrobianos de uso clínico. Revista FABICIB 5: 119-123.
27. Tyrrell GGJ, Senzilet LD, Spika JS, Kertesz DA, Alargaratnam M, Lovgreen M et al. (2000) Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study-1996. Sentinel Health Unit Surveillance System Site Coordinators. J. Infect. Dis. 182: 168-173.
28. Weisblum B (1985) Inducible resistance to macrolides, lincosamides and streptogramin type B antibiotics: the resistance phenotype, its biological diversity and structural elements that regulate expression - a review. J. Antimicrob. Chemother. 16 (Suppl A): 63-90.